ERBB2 and breast carcinoma: We show in this study that the knockdown of MALAT1 reduced the number of invaded cells induced by exogenous Wnt3 protein in HER2+ breast cancer cells, which suggests that MALAT1 may also interact with Wnt3 to induce cell invasiveness and decrease trastuzumab sensitivity in HER2+ breast cancer cells.